Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 9.


Hong, W David, Benayoud, Farid, Nixon, Gemma L, Ford, Louise, Johnston, Kelly L, Clare, Rachel H, Cassidy, Andrew, Cook, Darren AN, Siu, Amy, Shiotani, Motohiro
et al (show 24 more authors) (2019) AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 116 (4). pp. 1414-1419.


Turner, Joseph D, Sharma, Raman, Al Jayoussi, Ghaith, Tyrer, Hayley E, Gamble, Joanne ORCID: 0000-0001-7302-3412, Hayward, Laura, Priestley, Richard S, Murphy, Emma A, Davies, Jill, Waterhouse, David
et al (show 10 more authors) (2017) Albendazole and antibiotics synergize to deliver short-course anti-<i>Wolbachia</i> curative treatments in preclinical models of filariasis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 114 (45). E9712-E9721.


McGillan, Paul, Berry, Neil G ORCID: 0000-0003-1928-0738, Nixon, Gemma L, Leung, Suet C, Webborn, Peter JH, Wenlock, Mark C, Kavanagh, Stefan, Cassidy, Andrew, Clare, Rachel H, Cook, Darren A
et al (show 6 more authors) (2021) Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis. ACS Medicinal Chemistry Letters, 12 (9). pp. 1421-1426.


Johnston, Kelly L, Cook, Darren AN, Berry, Neil G ORCID: 0000-0003-1928-0738, Hong, W David, Clare, Rachel H, Goddard, Megan, Ford, Louise, Nixon, Gemma L, O'Neill, Paul M ORCID: 0000-0003-4338-0317, Ward, Stephen A
et al (show 1 more authors) (2017) Identification and prioritization of novel anti-Wolbachia chemotypes from screening a 10,000-compound diversity library. SCIENCE ADVANCES, 3 (09). eaao1551-.


Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Clare, Rachel H, Xie, Chunfang, Westhorpe, Adam, Hall, Steven R ORCID: 0000-0001-5314-4970, Edge, Rebecca J, Alsolaiss, Jaffer, Crittenden, Edouard, Marriott, Amy E, Harrison, Robert A
et al (show 2 more authors) (2022) In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. Toxicon: X, 14. p. 100118.


Clare, Rachel H, Bardelle, Catherine, Harper, Paul, Hong, W David, Borjesson, Ulf, Johnston, Kelly L, Collier, Matthew, Myhill, Laura, Cassidy, Andrew, Plant, Darren
et al (show 21 more authors) (2019) Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides. NATURE COMMUNICATIONS, 10 (1). 11-.


Albulescu, Laura-Oana, Westhorpe, Adam, Clare, Rachel H, Woodley, Christopher M, James, Nivya, Kool, Jeroen, Berry, Neil G ORCID: 0000-0003-1928-0738, O'Neill, Paul M and Casewell, Nicholas R
(2023) Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform. Frontiers in pharmacology, 14. p. 1331224.


Aljayyoussi, Ghaith, Tyrer, Hayley E, Ford, Louise, Sjoberg, Hanna, Pionnier, Nicolas, Waterhouse, David, Davies, Jill, Gamble, Joanne ORCID: 0000-0001-7302-3412, Metugene, Haelly, Cook, Darren AN
et al (show 12 more authors) (2017) Short-Course, High-Dose Rifampicin Achieves <i>Wolbachia</i> Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis. SCIENTIFIC REPORTS, 7 (1). 210-.


Clare, Rachel H, Dawson, Charlotte A, Westhorpe, Adam, Albulescu, Laura-Oana, Woodley, Christopher M, Mosallam, Nada, Chong, Daniel JW, Kool, Jeroen, Berry, Neil G ORCID: 0000-0003-1928-0738, O’Neill, Paul M
et al (show 1 more authors) (2024) Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors. Frontiers in Pharmacology, 14. 1328950-.

This list was generated on Mon Feb 12 05:49:46 2024 GMT.